ORKA Cash-Secured Put Strategy
ORKA (Oruka Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
ORKA (Oruka Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $2.37B, a beta of -0.25 versus the broader market, a 52-week range of 8.91-91, average daily share volume of 1.3M, a public-listing history dating back to 1997, approximately 28 full-time employees. These structural characteristics shape how ORKA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of -0.25 indicates ORKA has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. ORKA pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a cash-secured put on ORKA?
A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.
Current ORKA snapshot
As of May 15, 2026, spot at $61.89, ATM IV 74.80%, IV rank 4.02%, expected move 21.44%. The cash-secured put on ORKA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 98-day expiry.
Why this cash-secured put structure on ORKA specifically: ORKA IV at 74.80% is on the cheap side of its 1-year range, which means a premium-selling ORKA cash-secured put collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 21.44% (roughly $13.27 on the underlying). The 98-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ORKA expiries trade a higher absolute premium for lower per-day decay. Position sizing on ORKA should anchor to the underlying notional of $61.89 per share and to the trader's directional view on ORKA stock.
ORKA cash-secured put setup
The ORKA cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ORKA near $61.89, the first option leg uses a $60.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ORKA chain at a 98-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ORKA shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Put | $60.00 | $9.90 |
ORKA cash-secured put risk and reward
- Net Premium / Debit
- +$990.00
- Max Profit (per contract)
- $990.00
- Max Loss (per contract)
- -$5,009.00
- Breakeven(s)
- $50.10
- Risk / Reward Ratio
- 0.198
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.
ORKA cash-secured put payoff curve
Modeled P&L at expiration across a range of underlying prices for the cash-secured put on ORKA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$5,009.00 |
| $13.69 | -77.9% | -$3,640.69 |
| $27.38 | -55.8% | -$2,272.38 |
| $41.06 | -33.7% | -$904.07 |
| $54.74 | -11.5% | +$464.25 |
| $68.43 | +10.6% | +$990.00 |
| $82.11 | +32.7% | +$990.00 |
| $95.79 | +54.8% | +$990.00 |
| $109.47 | +76.9% | +$990.00 |
| $123.16 | +99.0% | +$990.00 |
When traders use cash-secured put on ORKA
Cash-secured puts on ORKA earn premium while a trader waits to acquire ORKA stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning ORKA.
ORKA thesis for this cash-secured put
The market-implied 1-standard-deviation range for ORKA extends from approximately $48.62 on the downside to $75.16 on the upside. A ORKA cash-secured put lets a trader earn premium while waiting to acquire ORKA at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current ORKA IV rank near 4.02% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ORKA at 74.80%. As a Healthcare name, ORKA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ORKA-specific events.
ORKA cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ORKA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ORKA alongside the broader basket even when ORKA-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on ORKA carry tail risk when realized volatility exceeds the implied move; review historical ORKA earnings reactions and macro stress periods before sizing. Always rebuild the position from current ORKA chain quotes before placing a trade.
Frequently asked questions
- What is a cash-secured put on ORKA?
- A cash-secured put on ORKA is the cash-secured put strategy applied to ORKA (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With ORKA stock trading near $61.89, the strikes shown on this page are snapped to the nearest listed ORKA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ORKA cash-secured put max profit and max loss calculated?
- Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the ORKA cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 74.80%), the computed maximum profit is $990.00 per contract and the computed maximum loss is -$5,009.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ORKA cash-secured put?
- The breakeven for the ORKA cash-secured put priced on this page is roughly $50.10 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ORKA market-implied 1-standard-deviation expected move is approximately 21.44%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a cash-secured put on ORKA?
- Cash-secured puts on ORKA earn premium while a trader waits to acquire ORKA stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning ORKA.
- How does current ORKA implied volatility affect this cash-secured put?
- ORKA ATM IV is at 74.80% with IV rank near 4.02%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.